Marapharm Ventures (CSE:MDN) has provided an update of timelines for its previously announced Las Vegas, Nevada project.
As quoted in the press release:
The two starter buildings have arrived at the Marapharm property located in Las Vegas, Nevada. Site preparation is underway. Forms and slab pour and cure time is slated to be January 16, 2017. The building erection crew is slated to begin January 17, 2017. Interior prep and finishing for grow ready is to commence January 28, 2017. Fencing, security and signage is projected for completionFebruary 20, 2017. Numerous construction items and interior furnishings, equipment and preparations to go to March 30, 2017 and growing, cultivation and processing for 3 licensed facilities commences April, 2017. Delivery of pre-sold cannabis after curing, testing and packaging projected to be within 3 months of the initial harvest.
“We are excited. Nevada has 50 million adult visitors per year and marijuana is legal for medical and recreational use so the market is beyond huge and we will be ready! Our land is paid for. The buildings, equipment and many other items are paid for. We are in good shape financially with close to $4 million in cash presently for working capital for the Las Vegas project and credit facilities are available if required. The building plans for the entire build-out will be ready shortly, to reflect the height changes to accommodate our vertical plus farming model, and then we go into the final construction stage. Construction photos will be posted shortly on our website,” Linda Sampson, Marapharm CEO.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).